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Abstract 
Background: Diabetes is one of the leading causes of death and disability in the United States 
including Kentucky. Despite advances in medicine, the current management of type 2 diabetes 
mellitus (T2DM) remains challenging. Poor self-management coupled with the increasing 
complexity of the disease can lead to poor glycemic control. 
Purpose: The purpose of this project was to examine current practices related to insulin-using 
patients’ treatment adherence and management of T2DM. In addition, providers’ perceptions on 
the management of T2DM were also assessed.  
Methods: A retrospective chart review and semi-structured interviews were conducted. Patients 
(N = 84) with T2DM, over the age of 18, with hemoglobin A1C > 7.5% and on insulin were 
included in the review. Providers (N = 5) were recruited for the interviews.  
Results: Despite a lack of assessment in patient adherence, glycemic control improved 
significantly at visit 2, demonstrated by a mean A1C reduction of 0.52% (p = 0.001). That 
change was found to be statistically significant between the group that received medication 
adjustments along with written education and those who did not receive any changes to their 
treatment plans. However, though not statistically significant, the most improvement in A1C was 
found among those who received medication changes along with verbal and written education.  
An inconsistency in the delivered education was also noted.  
Conclusion: Overall, the gap in care is in the assessment, documentation and education process 
at the practice. The findings suggest a great need for improvement in assessment and 
documentation of patient adherence, and development of a standardized diabetes education 
delivery model. Information from this project will help build a foundation for future quality 
initiatives to improve the delivery of diabetes education at primary care practices. 
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An Evaluation of Providers’ Interventions and Patients’ Adherence in Diabetes Management 
 
Introduction 
Diabetes is one of the leading causes of death and disability in the United States, and it is 
especially prevalent in Kentucky (Kentucky Cabinet for Health and Family Services; KCHFS, 
2015). From 2000 to 2013, the prevalence of diabetes in Kentucky adults increased from 6.5% to 
10.6%, with approximately 95% having type 2 diabetes mellitus (T2DM; KCHFS, 2015). As of 
2014, approximately 11% of adults in Louisville had been diagnosed with diabetes (Center for 
Health Equity, 2014). Despite advances in medicine, the current management of T2DM remains 
challenging. Poor self-management coupled with the increasing complexity of the disease can 
lead to poor glycemic control. The purpose of this practice inquiry project (PIP) was to examine 
current practices of providers at a primary care clinic related to patients’ adherence and 
management of their T2DM. The identification of a potential gap and barriers to diabetes 
management can lead to the development of evidence-based strategies to help providers and 
patients effectively manage T2DM.  
Background 
Diabetes, especially when uncontrolled, is associated with a number of complications such 
as retinopathy, nephropathy, neuropathy, and cardiovascular diseases. Diabetes is the leading 
cause of adult blindness, end-stage kidney disease, and non-traumatic lower-extremity amputation 
(KCHFS, 2015). Individuals with diabetes have a two to four-fold increased risk of developing 
coronary artery disease and stroke compared to non-diabetics (KCHFS, 2015). In a prospective 
cohort study, glycated hemoglobin (A1C) was found to be associated with mortality in patients 
who had poor glycemic control (Landman et al., 2010). The authors also found that 
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cardiovascular mortality risk in patients with an average A1C of equal or greater than 9% was 
three times higher than in patients with A1C of 6.5 to 7%.  
Diabetes not only increases the morbidity and mortality and compromises the quality of 
life of individuals affected by the disease, it also places a financial burden to the U.S. economy. 
The estimated total diabetes cost in the United States in 2012 was $245 billion and in Kentucky in 
2013, the cost was $3.85 billion (National Center for Chronic Disease Prevention and Health 
Promotion, 2014). Further, there is a positive correlation between diabetes complications, 
healthcare cost, and A1C (McBrien et al., 2012). 
There are many factors that affect diabetes management. Providers must recognize that the 
management of diabetes is very complex for most patients. A systematic review by Nam et al. 
(2011) found that a number of variables influence diabetes self-care behaviors consisting of 
physical, psychological and social factors. These factors include comorbidities, health beliefs, 
knowledge, health literacy, culture, financial resources, and social support (Nam et al., 2011). 
Literature Review 
Management of chronic disease and prevention of its complications is one of the main 
focuses of primary health care. T2DM is a chronic illness that requires continuous medical and 
self-care. In order to prevent complications and reduce morbidity and mortality, education on both 
the disease process and self-management is crucial. The ultimate goal of diabetes management is 
optimal glucose control that leads to reduction of cardiovascular risk and organ damage. 
Adherence to medication, self-monitoring of blood glucose (SMBG), diet and lifestyle change are 
associated with lower A1C (Schectman, Schorling, & Voss, 2008). Furthermore, every percentage 
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drop in A1C can reduce the risk of nephropathy, retinopathy, and neuropathy by 40% (KCHFS, 
2015).  
Primary care providers must deliver medical interventions and provide education to 
include physical activity and diet control. Interventions are best delivered when tailored to 
individual patients’ needs. Studies have demonstrated that diabetes education, such as lifestyle 
counseling, leads to reduction in A1C, diabetic complications, acute healthcare utilization, and 
total cost of health care (Martin & Lipman, 2013; Morrison, Shubina, & Turchin, 2012). In a 
systematic review, a significant association was noted between engagement in self-management 
education and decrease in A1C (- 0.80) (Chrvala, Sherr, & Lipman, 2015).  
 Self-Management 
Successful diabetes care requires not only the individualization of interventions but also 
treatment goals and glycemic targets. The American Diabetes Association (ADA) (2016) 
guideline recommends an A1C of less than 7% for most non-pregnant adults. However, more 
stringent A1C goals of less than 6.5% could be selected for certain patients, such as individuals 
that have no significant cardiovascular disease, have shorter duration of diabetes or lower risks for 
hypoglycemia (ADA, 2016).  
Personalized A1C goals of less than 8% may be appropriate for patients with a history of 
severe hypoglycemia, limited life expectancy, advanced vascular complications, and extensive 
comorbid conditions (ADA, 2016). In these patients, particularly older adults and adults at high 
risk for cardiovascular disease, more stringent A1C goals could lead to harmful adverse effects. 
An observational study based on four large randomized controlled trials found that for a majority 
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of adults over 65 years of age, the harms associated with A1C target lower than 7.5% or higher 
than 9% outweighed the benefits (Lipska, Krumholz, Soones, & Lee, 2016).  
Gerstein et al. (2008) conducted a long-term randomized study with more than 10,000 
T2DM patients who were at high risk for cardiovascular disease. Increased mortality rates were 
found in the intervention group with A1C goals of less than 6% as compared to the group with 
A1C goals of 7 – 7.9%. Based on these results and recommendations from the ADA, providers 
should individualize treatment and glycemic goals according to each patient’s needs and 
characteristics. Strategies for improving persistent poorly-controlled diabetes mellitus includes: 
being cognizant of patients’ lifestyles, medication regimens and comorbid conditions, and 
addressing barriers to self-management (Crowley et al., 2014).  
Recognition and proper management of co-existing physical and psychological conditions 
are beneficial in improving diabetes management. Patients with multiple comorbidities have been 
found to frequently experience barriers to self-management due to competing health and financial 
demands (Jerant, Friederichs-Fitzwater, & Moore, 2005). Results of a cross-sectional study 
showed a significant association between multiple comorbidities and lower perceived health 
status and lower levels of physical functioning in older adults (Bayliss, Ellis, & Steiner, 2007). 
Psychological conditions such as depression and other emotional stresses are potential 
barriers to optimal glycemic control. This is due to the fact that mental health can affect patients’ 
perceptions about the disease and their self-management behaviors. Depression is also associated 
with increased morbidity, mortality, functional limitation, and increased health care costs (Chao, 
Nau, Aikens, & Taylor, 2005). In a systematic review and meta-analysis, depression was found to 
be associated with a 1.5-fold increased risk of mortality in people with diabetes (Van Dooren et 
PROVIDERS' INTERVENTIONS AND PATIENTS' ADHERENCE   
6 
 
al., 2013). Lack of awareness from providers regarding patients’ psychological health also affects 
diabetes management. Yet, Peyrot et al. (2005) reported that providers expressed a lack of 
confidence in their ability to identify and treat psychological problems in patients with diabetes. 
Other factors have been associated with successful self-management. For example, the 
financial strain placed upon individuals and their families cannot be understated. In a 
retrospective cohort design, general financial and medication-specific financial strain was found 
to be significantly associated with medication non-adherence, even after income adjustment 
(Lyles et al., 2016). In addition, family and social support are closely associated with self-care. 
Mayberry and Osborn (2012) found that patients with non-supportive family members reported 
lower adherence to their medication regimens and had poorer glycemic control. This finding 
suggests that social support should be a valuable factor for providers to assess in addition to 
financial strain.  
Medical Management 
Proper management of diabetes should include the evaluation of each patient’s physical, 
psychological, and social factors as mentioned above. In addition, a study by Schectman et al. 
(2008) found that adherence to appointments was a strong predictor of glycemic control and that 
missed appointments should be assessed as a barrier to diabetes self-management. These potential 
barriers should be identified and minimized.  
Understanding the clinical interventions and barriers of diabetes management from a 
provider’s point of view can lead to quality improvement initiatives. Diabetes management is not 
only influenced by patients’ self-care behaviors but also providers’ interventions, such as 
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pharmacotherapy and education. Providers’ attitudes, perceptions, beliefs, and knowledge about 
diabetes management can have an impact on their strategies. Results of the Diabetes, Attitudes, 
Wishes, and Needs study revealed that a provider’s prescription practice was associated with his 
or her perception of patients’ behaviors (Peyrot et al., 2005). These providers reported that they 
were likely to delay the initiation of insulin therapy if they perceived their patients to be less 
adherent to medication or appointment regimens (Peyrot et al., 2005).  
There are substantial data to support the importance of assessing adherence, comorbidities, 
management strategies, potential barriers, and providers’ perceptions in patients with diabetes. A 
systematic approach with interventions that focus on healthy lifestyle change, self-management, 
prevention of complications, and education can lead to optimal management of diabetes mellitus 
(ADA, 2016).  However, due to the intricacy of the disease, achievement of optimal diabetes self-
management and glycemic control often remains an arduous task. Therefore, the process of 
continuous quality improvement can identify treatment gaps and potential barriers and guide 
providers to improve the quality of diabetes healthcare services.  
Purposes 
 This practice inquiry project (PIP) was conducted at an outpatient primary care practice 
located in south of Kentucky. The clinic provides services such as disease prevention, health 
maintenance, diagnosis and treatment of acute illnesses, and management of chronic conditions. 
The clinic also serves as the community’s access to most health care services. This primary care 
practice includes four physicians, three nurse practitioners, and one nurse navigator. This practice 
has a large population of diabetics and there has been no evaluation of the process and outcomes 
of their current diabetes management.  
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The two main purposes of this project were to: 1) evaluate current management practices 
of patients with T2DM who currently have an A1C of greater than 7.5 and are on insulin therapy, 
and 2) identify treatment gaps between current practice and target goals with input from the 
clinical providers. The specific objectives were to: 
1. Assess patients’ comorbidities and medication regimen. 
2. Assess documented patients’ adherence to recommended treatment. 
3. Describe diabetes-related interventions implemented by providers. 
4. Assess changes in A1C between two subsequent visits.  
5. Assess any potential barriers to treatment and self-management documented in 
providers’ notes.  
6. Assess for any missed appointments related to diabetes visits and referrals.  
7. Assess providers’ perceptions toward T2DM protocols/guidelines, perceived barriers, 
and utilization of diabetes self-management programs. 
Methods 
Study Design  
This gap analysis involved a retrospective chart review of patients with T2DM with an 
A1C greater than 7.5% who were on insulin therapy. Data collected on patient demographics 
included: gender, age, ethnicity, medical coverage, marital status, body mass index (BMI), and 
smoking status. Patients’ comorbidities were evaluated. In Appendix A, the survey instrument 
with a complete list of the variables is provided. For examples, conditions such as hypertension, 
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hyperlipidemia, and depression were assessed. The medication regimen was also evaluated to 
include other diabetes medications in addition to insulin. 
Patients’ adherence was evaluated based on a diabetes follow-up visit template that was 
built into EPIC which is an electronic medical records (EMR) system. The template includes 
assessment of each patient’s subjective evaluation of their self-care management. Variables such 
as overall adherence to medical plan along with SMBG, current diet, meal planning, and exercise 
were reviewed.  
Types of diabetes-related interventions along with referrals to a Diabetes Self-
Management Education (DSME) program, dietician, or nurse navigator were evaluated at visit 1. 
Interventions such as verbal education, medication adjustments and diabetes written materials 
(handouts) were targeted. Verbal education is delivered by providers, licensed practical nurses 
(LPN), or medical assistants (MA). Patients can also receive education through mailed letters or 
the MyChart service within the EMR. The MyChart program is available to all patients; it gives 
them immediate access to their charts and allows for communication with providers through 
emails. Changes in A1C between visit 1 and visit 2 were evaluated and how the interventions and 
delivery methods impact that change. Data regarding potential barriers and missed appointments 
documented in providers’ notes were included in the analysis.  
In order to evaluate providers’ perspectives regarding optimal management of T2DM, 
focused interviews were conducted. Five primary care providers practicing at the target facility 
(two nurse practitioners and three physicians) were asked to respond to questions about the 
management in patients’ adherence to recommended treatment guidelines. In Appendix B is an 
outline of the questions. 
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Informed Consent Process 
This PIP was a retrospective chart review along with a targeted interview with providers. 
Protection of human subjects was obtained from the University of Kentucky’s Institutional 
Review Board (IRB). The Healthcare Office of Research Administration associated with the 
practice also approved the project proposal (see Appendix C for copy of IRB approval letter). 
Providers were consented prior to the interviews (see Appendix D for a sample of consent form).  
Subject Recruitment  
The inclusion criteria included: 1) all primary care patients at the clinic; 2) had two 
diabetes follow-up visits within the year of 2015 with an ICD-9 or ICD-10 diagnosis code for 
T2DM or uncontrolled T2DM; 3) over the age of 18 and not pregnant; 4) had an A1C of greater 
than 7.5% and on insulin therapy; and 6) currently not being managed by an endocrinologist. 
Charts of patients not meeting these criteria were excluded from the study. After evaluating the 
EMRs of 140 patients, only 84 met the specified inclusion criteria.  
Providers were contacted and invited to participate in a face-to-face semi-structured 
interview that would last approximately 15 minutes. The purpose of the interview was explained 
to each provider. Participation was strictly voluntary. Interested providers were provided with 
informed consents explaining what the project was about and what they would be expected to do 
if they agree to participate. All results were recorded in writing and transferred to an electronic 
Microsoft Word document.  
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Study Procedures  
Medical records were accessed through EPIC which is an electronic, secure, encrypted, 
firewall protected EMR. Using the data collection form in Appendix A, chart audits were 
conducted in a workroom at the Nursing Institute at a medical building. Data were de-identified 
by assigning each patient a unique patient identifier number. A separate worksheet was used to 
link the patient EMRs to the correlating unique patient identifier numbers. This worksheet was 
stored separately from the data in an authenticated secure, firewall protected folder. The 
worksheet was permanently deleted upon conclusion of the data analysis.  
The providers’ interviews were confidential and did not contain any identifying 
information. Providers’ names and years of experience were not recorded; their roles (e.g., 
APRNs, MDs) were not linked to patient outcome data.  Privacy of the individual interview was 
ensured thusly: Each interview was conducted in a private room at the office, and only the 
provider and the interviewer were present during the interview. Providers’ data were collected on 
handwritten papers during the interview and transcribed into electronic Word documents. All 
paper records were destroyed after the information was transferred into electronic documents. 
All data collected were stored on a password protected, identity authenticated secure, 
firewall protected research folder. The information services representatives did not access the 
folder; no technical issues were encountered during the study. All data were permanently deleted 
upon conclusion of the data analysis.  
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Data Analysis  
 Collected data were recorded into an SPSS spreadsheet. The SPSS software version 22 
was used for statistical analysis. The University of Kentucky College of Nursing statistics 
department was utilized to help analyze data obtained from the study. Descriptive statistics 
including frequency distribution were utilized to assess the patients’ demographic variables, 
patients’ adherence and providers’ interventions. The duration of time between two visits was 
also evaluated using descriptive statistic.  
The paired t-test was utilized to compare changes in glycemic control between the first 
and second visit. Means (M) and standard deviations (SD) were used to describe changes in A1C 
between the initial and follow-up visit. Spearman correlation coefficient was utilized to assess the 
relationship between the number of comorbidities and A1C. One-way analysis of variance 
(ANOVA) with post-hoc analysis was utilized to analyze the impact of interventions and delivery 
methods on A1C changes. A p-value of less than 0.05 was used to determine significance for all 
the statistical tests.  
Results 
Sample Characteristics 
 Patients’ demographic data including gender, race, medical coverage, marital status, 
smoking status and medication regimen are reported in Table 1. The entire sample (N = 84) was 
Caucasian, male (58%), married (60%), non-smoker (88%), with a mean age of 64 years (range 
28 - 83) and had Medicare coverage (68%). All patients were insulin-treated T2DM with a 
majority of them being on dual or triple therapy. 
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Comorbidities  
 Physical comorbidities in this sample are represented in Figure 1. The most prevalent 
comorbidities were hyperlipidemia (87%), hypertension (86%), and obesity (73%). Among the 
psychological comorbidities, anxiety (27%) and depression (23%) were the most common. 
Overall, the average number of comorbidities among all patients was five, with a range of one to 
eleven. There was a weak, positive relationship between the number of comorbidities and A1C  
(r = 0.23, p = 0.04).  
Adherence 
Between the two visits, the two areas most likely to be assessed were SMBG (31% and  
32%) and current diet (32% for each visit). Within those completing SMBG (81% and 74%), the 
majority were testing one to two times per day. For those having a diet evaluation, most reported 
following a low salt diet (Table 2). For the 15% of patients that were assessed for meal planning 
at visit 1 and 14% at visit 2, the majority of them did not participate in meal planning. Physical 
activity was rarely engaged upon by those who were evaluated for this variable. When looking at 
the same patients that were assessed for the same criteria at both visits, it appears that SMBG 
(21%) and diet (30%) were the most likely to be discussed.  
Glycemic Control  
The paired t-test was utilized to compare changes in glycemic control between visit 1 and 
visit 2. There was a statistically significant decrease in the A1C from the first visit (M = 9.15, SD 
= 1.26) to the second visit (M = 8.63, SD = 1.39; p = 0.001). The mean decrease in A1C was 
0.52 with a 95% confidence interval ranging from 0.23 to 0.81.  
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Intervention 
 
Interventions that were implemented for visit 1 were evaluated. These included: 
medication adjustments, referrals, and education. The types of education encompassed verbal 
instruction and written information. The verbal instruction was either given at the point of care 
by the provider or after the visit, delivered through the ancillary office staff (LPN/MA). After 
evaluating the data, the decision was made to differentiate the education into the generic scripted 
handout and those that received individualized verbal instruction. This latter group encompassed 
those that received verbal education at the office visit, those who were mailed results with a 
personalized message and those who received a message via email (MyChart).  
Interventions were found to vary across the sample (see Figure 2). A majority of patients 
(61%) received the scripted outline of general diabetes self-management (SMBG, diet, physical 
activity, medication adherence, foot and eye care). Based the chart review, 27% of the sample 
received the written handout and medication adjustments. Approximately 17% received verbal 
and written instructions regarding their A1C and 8% received medication adjustments along with 
verbal and written education. There were five patients who were only told no changes would be 
made to their medical management.  
ANOVA was conducted to explore the impact of interventions on A1C changes from 
visit 1 to visit 2. Among the eight groups, there was a statistically significant difference in A1C 
changes between the two groups (F = 2.36, p = 0.31). Post-hoc comparisons using the Tukey 
HSD test found that the mean difference in A1C for the group that were told to continue 
treatment (M = + 1.06, SD = 1.54) was significantly different from those that received 
medication adjustments along with diabetes handout (M = - 0.91, SD = 1.36; p = 0.04). No 
significant difference between the other groups was found. Though not reaching statistical 
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significance, the group that received a combination of medication adjustment, verbal and written 
instructions was found to have the highest improvement in A1C (M = - 1.17; p = 0.40) (Figure 
3).  
Delivery mode. Intervention delivery methods were also assessed. Only 18% of the 
sample patients had A1C results at the time of their first visit for providers to address face-to-
face. The majority of patients (n = 69, 82%) did not have their A1C results at the first visit. 
Rather the lab test was drawn at the conclusion with results communicated afterward along with 
treatment recommendations. The results and treatment recommendations were then 
communicated to patients by either an LPN (19%) or MA (46%). Result letters along with 
treatment recommendations were mailed to 30% of the patients and 4% received the information 
from providers through MyChart. ANOVA was conducted to explore the impact of each method 
of communication on A1C changes from visit 1 to visit 2. There was no statistically significant 
difference in A1C changes between the groups (p = 1.41).   
Barriers 
 A total of 14% of patients have documented barriers to diabetes treatment. These 
included: physical impairment (limited activity due to the use of wheelchair and cane, and back 
problem), lack of desire to learn (patient stated that he or she knew what should be done but did 
not want to do it, patient was minimally interested in committing to lifestyle changes), memory 
impairment (forgetfulness), depression, and family dynamic (caregiver strain). Furthermore, 
financial strain was found to be the most prevalent (8%). Documented financial strain included 
inability to afford diabetes medications and supplies, ophthalmology and podiatry care, and 
healthy food.  
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Follow-up Visits 
 Documentation of any missed appointments was evaluated during the retrospective chart 
review. A majority of patients did not have documentation of missed appointments, only 5% did 
not show up to their appointments as scheduled. The average duration between the two visits was 
130 days. 
Providers’ Interviews  
 Three physicians and two nurse practitioners participated in the interview. This represents 
70% of all full-time primary care providers working at the clinic. The findings of the interview 
were grouped into four main themes including guideline, education, barriers, and 
recommendations.  
 Guideline. More than half of the providers (60%) reported utilizing the ADA guideline 
when providing care for patients with T2DM. The usual A1C goal for all patients was less than 
7%. However, a less stringent A1C goal of less than 8% was reported to be appropriate for some 
patients that have an extensive history of cardiac disease.  
 Education. All providers refer patients that were newly diagnosed or not meeting A1C 
goals to their nurse navigator for self-management and nutritional counseling. Dietician referrals 
were reported by 40% of the providers but mostly for newly diagnosed patients. One provider 
reported that he refers less than 10% of his patients for diabetic counseling due to patients not 
wanting to go. All providers utilize diabetes handouts to provide patients with information such 
as medications and lifestyle modifications. Most providers (80%) felt that the printed education 
materials would be helpful if the patients took time to read them. The reading materials should 
facilitate patients to ask important questions related to their diabetes care at follow-up visits. The 
providers did not know if patients were utilizing what was being given to them.   
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 Barriers. Some perceived barriers that prevent patients from adhering to their treatment 
plans were mentioned by the providers. These barriers included: financial strain such as inability 
to afford healthy foods and medications, lack of insurance coverage, co-existing mental health 
issues, lack of understanding of disease course, lack of desire to learn, lack of self-motivation 
(e.g., some patients did not want to follow-up every three months and some patients even 
requested to be seen every year), and health literacy. In addition, access to a certified diabetes 
educator (CDE) was limited. Currently, appointments to meet with a CDE were booked out a full 
year in advance. 
 Recommendations. Some recommendations were suggested by the providers for 
improving the current practice of diabetes management. These recommendations included: 
individualized diabetic education across visits, education on best practices and nutrition 
counseling, utilization of the nurse navigator for newly diagnosed patients, and having a focus on 
physical activity and weight control.  
Discussion 
 This PIP, using both quantitative and qualitative methods, aimed to examine the current 
management of patients with T2DM. Also treatment gaps to achieve optimal glycemic control 
were evaluated. In this practice, among a group of insulin-using T2DM patients who were not at 
glycemic goal, there was a reduction in the mean A1C between two visits. A number of issues 
were noted in the documented records that offer strategies for improvement. 
The results revealed a significant decrease in A1C from visit 1 (M = 9.15%) to visit 2 (M 
= 8.63%). As reported by the providers, the usual A1C goal for most patients is less than 7%. 
However, for some patients with an extensive history of cardiac disease or multiple comorbid 
conditions, a goal of less than 8% was selected by some providers. The individualization of 
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glycemic targets by providers is consistent with recommendations from the ADA (2016) and 
several other research findings (Gerstein et al., 2008; Lipska et al., 2016).   
Even though there was a significant improvement in A1C among the sample, 8.6% is still 
above the target goal of 7 – 8%. Perhaps this could be due to the comorbidity burden among the 
patients included in the project. Several studies have identified the negative effects of co-existing 
chronic conditions on diabetes self-management (Bayliss et al., 2007; Jerant et al., 2005), 
including frequent barriers to self-care, and lower perceived health status and physical 
functioning. The average comorbidities per patient were five and more than 70% of patients had 
hyperlipidemia, hypertension, and obesity. In this sample, high number of comorbidities was 
found to associate with higher A1C (p = 0.04).  
In addition to the physical comorbidity burden found among the study sample, 23% of 
patients had depression and 27% of patients had anxiety. This result is consistent with a previous 
study by Bot, Pouwer, Zuidersma, Van Melle, and De Jonge (2012), which found that the 
prevalence of depression among patients with diabetes is more than three times higher than the 
general population, 20 - 25% in comparison to 6.7%. Furthermore, depression can lead to poor 
glycemic control and worsened health status (Holt et al., 2014). However, these findings are 
limited in their importance as the current treatment of these conditions was not evaluated.  
According to the ADA (2016), assessment of patients’ adherence should be a priority in 
diabetes management. Assessment of the patient’s adherence to treatment, SMBG, diet, and 
physical activity is essential at each diabetes visit. The continuous evaluation of patients’ 
adherence allows providers to identify the causes of hyperglycemia and to modify treatment 
approaches accordingly. However, based on the results of this project, adherence to treatment 
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was not consistently assessed or documented by the providers at both visits. Therefore, it was 
difficult to evaluate for an overall improvement in self-management behaviors.  
Patients’ perceptions of adherence to treatment were evaluated in less than 10% of 
patients at both visits. Interestingly, the changes in adherence, though not significant, were found 
to correlate with the changes in A1C among these patients. Understanding how patients perceive 
their own self-management in total allows for a starting conversation about self-management. It 
can be thought of as similar to a pain scale, wherein self-evaluation can be made.  
 Only a third of the sample (31%) was questioned regarding SMBG, within this group 
81% were completing SMBG at visit 1 and 74% at visit 2.  It was difficult to evaluate patients’ 
adherence to SMBG because the recommended regimen was not documented in the charts. The 
evaluation of patients’ SMBG at each visit can mitigate the under or overuse of SMBG. This 
important self-management tool recommended by the ADA (2016) for all insulin-treated 
diabetics was not fully utilized by all patients.  
Providers should ensure that patients incorporate glucose values into their self-
management plans. Interventions, such as adjusting insulin dosage, food intake, and exercise to 
achieve target fasting blood glucose, are the ultimate goal (ADA, 2016). Frequent SMBG can 
reduce patients’ risk of hypoglycemia and help them identify factors that cause hyperglycemia 
(Elgart, Gonzalez, Prestes, Rucci, & Gagliardino, 2015). In this retrospective chart review, all the 
patients were on insulin therapy during the time of evaluation; therefore it is critical that these 
patients monitor their glucose on a daily basis. 
 Diet and exercise were not consistently assessed by providers at each visit. Most who 
were asked reported being on a low salt diet with very few engaged in actual meal planning. 
Possibly, the high prevalence of co-existing hypertension among the patients accounted for their 
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report of limiting salt intake. It may also be that diabetic meal planning is far more complicated 
than focusing on eliminating just salt from the diet. Exercise was also rarely asked by the 
providers with essentially no one participating in routine exercise.  
Physical activity and nutrition are the foundation of T2DM self-management. The ADA 
strongly recommends that both are routinely discussed with diabetics. A1C levels have been 
shown to decrease not only with routine exercise but also with the level of intensity (Boule, 
Haddad, Kenny, Wells, & Sigal, 2001; Boule et al., 2003). Furthermore, the ADA (2016) 
recommends either carbohydrate counting for patients on insulin or having a fixed amount of 
daily carbohydrates. Each of these lifestyle modifications requires continual reinforcement for 
long lasting behavioral change.  
Interestingly, the providers in this analysis cited both exercise and diet as being the 
cornerstone of diabetes management. Yet this was not reflected in the chart review. Though, a 
nutritionist and the DSME program were available for these patients, very few had been referred 
for those services. A CDE was also available but those appointments are booked a full year in 
advance. The A1C in the sample did decrease most when medication changes were made along 
with verbal and written education. Possibly, education was delivered but not charted and 
previous referrals were not captured. Unfortunately, patients were not interviewed to assess the 
amount of education delivered.  
One of the most common perceptions frequently expressed by the providers was that they 
did not feel their patients were interested in attending classes or meeting with the dietician. This 
may be why so few referrals were made. Even visits with the nurse navigator to provide self-
management and nutritional counseling were not utilized. One might surmise that either the 
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providers lost faith in their patients’ willingness for self-management or they were discussing 
this with the patients who refused the referral.  
Chronic disease management is not easy for either providers or patients. Patients have to 
make lifestyle changes that are foreign to many of them. Oftentimes, they see the management 
within the purview of the providers and the solution is medications. This leads to a strained 
relationship between providers and patients. Providers get frustrated, leading to generalizations 
about patients, i.e. “nobody will exercise or eat right”, and patients are overwhelmed. Hence, it is 
it is easier to eliminate dietary salt than staying away from satisfying carbohydrates.  
In this analysis, two-thirds of the sample had a medication adjustment based upon their 
A1C. The ADA (2016) emphasizes the importance of a patient-centered pharmacological therapy 
along with lifestyle modifications. In this sample, patients who received medication changes 
along with some type of education had the most improvement in their A1C. This reemphasizes 
the importance of providing education along with medication adjustments. If only medications 
were adjusted, the message patients might receive is that medications are more important than 
lifestyle changes. Unfortunately, the inconsistent charting made it difficult to draw firm 
conclusions.  
There was no consistency in the education that was charted in this gap analysis. A 
systematic and structured model would ensure that each patient receives the same standard of 
quality diabetes education consistent with the ADA guideline. The evaluation of clinic’s resources 
and personnel are imperative in designing an effective standardized model of diabetes education. 
However, with the lack of access to a CDE, the nurse navigator will probably take on an essential 
role. There is evidence that a nurse-driven standardized diabetes education process when 
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embedded in a primary care practice significantly improves patient’s A1C (Mendez et al., 2016; 
Stellefson, Dipnarine, & Stopka, 2013).   
 A systematic approach to successful diabetes management requires not only the 
implementation of patient-centered interventions but the exploration of barriers to adherence. 
Lyles et al., (2016) emphasize the importance of assessing financial factors in achieving 
adequate glycemic control. Though only 14% of the sample had documented barriers, financial 
strain was the most commonly reported. Due to the sample size (n = 12), correlation with A1C 
and reported barriers was not performed. However the average A1C of patients within this group 
was higher than the overall average A1C of the entire sample from visit 1 and visit 2 (10.05% 
and 9.06% compared to 9.15% and 8.63%, respectively). This might be an area the nurse 
navigator could address and assist patients in finding affordable options, i.e., pharmaceutical 
patient assistance program.  
Effective self-care behaviors entail adherence to treatment, such as medication, diet, 
physical activity, and follow-up appointments. A study by Schectman et al., (2008) found that 
adherence to appointments was a strong predictor of glycemic control. In this sample, only 5% of 
patients missed their scheduled appointments. This sample did comply with recommended 
follow-up visits and may indicate the emphasis they placed on attending their scheduled 
appointments. What remains in question is their commitment to lifestyle modifications.  
Limitations 
The design of this PIP as a retrospective chart review from one setting has several 
limitations. First, the relatively small sample size of the analysis (N = 84) limits the 
generalizability of the findings. Second, the sample from one setting is not a representative of the 
general diabetes population at other primary care clinics. There was no diversity in the sample; 
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therefore, these findings might not be applicable to other ethnic groups due to different cultural 
backgrounds. The results are subject to confounding risk factors that were not measured but 
could have an impact on glycemic control, such as hospitalization between visits, steroid therapy, 
and acute illness.  
This project used existing medical records and providers’ interviews to generate 
information for quality improvement initiatives. A paucity of information regarding patients’ 
adherence was noted in the study results, which could be due to insufficient assessment or 
documentation from the providers. However, due to the limited scope of the project, this was not 
fully explored.  
One limitation of the qualitative data is that it was not obtained from the insights of 
patients with T2DM. In-depth interviews with patients would provide an accurate assessment of 
their knowledge, self-care behaviors, and barriers to treatment. The triangulation of various 
sources of data would provide a more thorough analysis of patients’ adherence and factors that 
affect glycemic control.  
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Conclusion 
Despite the above limitations, the findings from this practice inquiry project contribute to 
the literature by emphasizing the importance of continuous diabetes management. Optimal 
diabetes management entails comprehensive assessment and evidence-based individualized 
interventions. Specifically, a comprehensive assessment that should occur at each follow-up visit 
needs to include patient’s self-care behaviors, comorbid conditions, barriers to self-management, 
and treatment strategies. This is especially important for the improvement of glycemic control in 
patients with persistent poorly-controlled diabetes mellitus. 
Overall, the gap in care seems to lie in the assessment, documentation and education 
process at the practice. Despite poor assessment of patient adherence, there was a significant 
improvement in A1C. This could indicate that there is an issue with documentation among the 
providers.   
The results of this project have several valuable clinical implications. The findings 
suggest a great need for improvement in assessment and documentation of patient adherence, and 
development of a standardized diabetes education delivery model. A future project is needed to 
explore the utilization and effectiveness of a non-CDE nurse in providing DSME to patients. 
Information from this project will help build a foundation for future quality initiatives to improve 
the delivery of diabetes education at primary care practices. 
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Table 1 
Study Demographics 
 
 
 
 
 
 
 
 
STUDY DEMOGRAPHICS 
 
Variable Number/Percent 
 
Gender  
Males 49 (58.3%) 
Females 35 (41.7%) 
 
Race 
 
Caucasian 84 (100%) 
 
Medical Coverage 
 
Private 22 (26.2%) 
Passport 5 (6%) 
Medicare 57 (67.9%) 
 
Marital Status 
 
Single 8 (9.2%) 
Married 50 (59.5%) 
Divorced 10 (11.9%) 
Widowed 14 (16.7%) 
Unknown 2 (2.4% 
 
Smoking status 
 
Smoker 10 (11.9%) 
Non-smoker 74 (88.1%) 
 
Medication Regimen 
(including insulin) 
 
Mono therapy 7 (8.3%) 
Dual therapy 39 (46.4%) 
Triple therapy 33 (39.3%) 
More than three medications 5 (6%) 
 
TOTAL 
 
84 (100%) 
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Table 2 
Patient’s Subjective Evaluation of Adherence Assessed at Each Visit  
 
ADHERENCE PATIENTS (numbers & percentage) 
 
 Visit 1 Visit 2 
 
Compliance with treatment 
 
n = 7 (8%) 
 
n = 11 (13%) 
“None of the time” 0 (0%) 0 (0%) 
“Some of the time” 2 (28%) 2 (18%) 
“Most of the time” 3 (43%) 1 (9%) 
“All of the time” 2 (29%) 8 (73%) 
 
Glucose monitoring 
 
n = 26 (31%) 
 
n = 27 (32%) 
None 5 (19%) 7 (26%) 
1 – 2 x / week 1 (4%) 0 (0%) 
3 – 4 x / week 1 (4%) 0 (0%) 
1 – 2 x / day 14 (54%) 14 (52%) 
3 – 4 x / day 5 (19%) 6 (22%) 
 
Current diet 
 
n = 31 (37%) 
 
n = 31 (37%) 
Generally healthy diet 6 (19%) 3 (10%) 
Generally unhealthy diet 5 (16%) 7 (22%) 
Low salt diet 20 (65%) 21 (68%) 
 
Meal planning 
 
n = 13 (15%) 
 
n = 12 (14%) 
None 10 (76%) 7 (58%) 
ADA exchange 1 (8%) 0 (0%) 
No concentrated sweets 1 (8%) 3 (25%) 
Dietician visit 1 (8%) 2 (17%) 
 
Physical Activity 
 
n = 14 (17%) 
 
n = 13 (15%) 
None 4 (29%) 3 (23%) 
Rarely 9 (64%) 8 (62%) 
Intermittently 1 (7%) 2 (15%) 
 
TOTAL 
 
N = 84  
 
N = 84  
 
 
 
 
 
 
 
PROVIDERS' INTERVENTIONS AND PATIENTS' ADHERENCE   
32 
 
 
 
Figure 1. Comorbidities . 
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Figure 2. Documented Interventions (N = 84). 
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Figure 3. A1C changes (Visit 1 – Visit 2). 
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Appendix A 
Proposed Data Collection Instrument 
 
Patient Identifier: _____ Diagnosis Code: _____ Gender: male/ female/ transgender Age: ___ 
 
Race/ethnicity: Caucasian / African-American / Hispanic / Asian / other     
 
Medical coverage: none / private / Passport / Medicaid / Medicare    
 
Marital status: single /married / divorced   
 
Height: _____ Current Weight: ________ Last visit weight: ________ BMI:______                
 
Visit: 1 or 2 (if 2, how many days apart) ____________ Smoking status: smoker/non-smoker 
 
Medication regimen: Oral 
 Monotherapy ________ 
 Dual therapy____________ & ____________ 
 Triple therapy ___________ & ____________ & ______________ 
Insulin 
 ______________________________________________________ 
Co-morbidities: retinopathy / neuropathy / foot ulcer / cardiovascular disease (CAD/PVD/CVA) 
/ chronic obstructive pulmonary disease (COPD) / nephropathy / obesity / hypertension / 
hyperlipidemia 
 
Level of provider: physician / physician assistant / nurse practitioner  
 
Adherence:  
 
Subjective evaluation of compliance with recommended treatment:  
All of the time/ most of the time/ some of the time/ none of the time 
 
Glucose monitoring regimen:  
5 + x per day/ 3 – 4 x per day/ 1 – 2 x per day/ 3 – 4 x per week/ 1 – 2 x per week 
 
Current diet: diabetic/ generally healthy/ unhealthy/  
        high fat & cholesterol/ low fat & cholesterol/  
        high salt/ low salt/ vegetarian 
 
Meal planning: none/ ADA exchange/ no concentrated sweets/ calorie counting/ carb counting/ 
dietician visit 
 
Exercise: daily/ every other day/ three times a week/ weekly/ intermittent/ none 
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Provider’s education:  
 diet/physical education __________________________________________________ 
 acute complications (hypoglycemia/ hyperglycemia/ sick day)____________________ 
 chronic complications (daily foot exam/ proper footwear/ annual eye exam/ podiatry 
visit)__________________________________________________________________ 
 other diabetes related education (i.e., glucose monitoring)________________________ 
referral to Diabetes Self-Management Education _______________________________ 
Potential barriers documented in notes: 
 cultural/religious ________________________________________________________ 
 emotional (e.g., fear of needles) ____________________________________________ 
 lack of desire to learn ____________________________________________________ 
 depression _____________________________________________________________ 
 mental disability ________________________________________________________ 
 family dynamic _________________________________________________________ 
 physical impairment (speech/visual/hearing)___________________________________ 
 financial _______________________________________________________________ 
A1C level:  ________   
Was this done prior to visit or after visit: 
        If this was done prior to visit: 
o Provider’s interventions:  
 diet/ physical activity education __________________________ 
 oral medication added or adjusted ________________________ 
 insulin added or adjusted _______________________________ 
If this was done after visit: 
 Who notified the patient:___________________ 
 What was done: __________________________ 
o Provider’s interventions:  
 diet/ physical activity education ___________________________ 
 oral medication added or adjusted _________________________ 
 insulin added or adjusted ________________________________ 
 
 When was the patient scheduled for follow-up: ________ 
o Did the patient follow-up: YES/ NO 
 If YES – Go to next visit 
 If NO – Missed appointments: no-show/ rescheduled / rescheduled & kept/ 
cancelled 
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Appendix B 
Interview questions 
 
1. Do you use to any guideline when providing care for patients with T2DM? If so, which 
one do you use?  
 
2. How often do you refer your patients for diabetes self-management education and what 
are your thoughts on that? 
 
3. What are some barriers that you have encountered as a provider in helping your patients 
who have T2DM reduce their A1C level?  
 
4. What are some perceived potential barriers that prevent your patients from adhering to 
their treatment plan? Such as cultural/religious, emotional (e.g., fear of needles), lack of 
desire to learn, depression, mental disability, family dynamic, physical impairment 
(speech/visual/hearing), financial, health literacy, or other?  
 
5. What educational materials do you provide to your patients that have T2DM? Do you 
utilize the printed educational material in the after-visit summary or other? 
 
6. Do you think that providing printed educational materials to patients with T2DM is 
helpful in reinforcing the successful management of T2DM? (list 7 core behaviors of 
ADA) (healthy eating, being active, monitoring, taking medication, problem 
solving, reducing risks and healthy coping. 
 
7. For your patients, what is the usual A1C goal? 
 
8. What are your recommendations for improving current practice of diabetes self-
management in patients that are not reaching their A1C goal? 
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IRB Letter of Approval 
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Appendix D 
Sample of Consent Form 
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